REAL-WORLD EVIDENCE OF BRENTUXIMAB VEDOTIN (BV) CONSOLIDATION AFTER AUTOLOGOUS TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA (RRHL): 2-YEAR FOLLOW-UP OF GATLA RRHL STUDY